⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19050605 | 0.83 | — | — | |
| SCHEMBL26351161 | 0.80 | — | — | |
| SCHEMBL21111312 | 0.77 | — | — | |
| SCHEMBL15471299 | 0.76 | — | — | |
| SCHEMBL10093882 | 0.74 | — | — | |
| SCHEMBL26270164 | 0.73 | — | — | |
| SCHEMBL23815560 | 0.70 | — | — | |
| SCHEMBL19286533 | 0.70 | — | — | |
| SCHEMBL24854094 | 0.69 | — | — | |
| SCHEMBL21969432 | 0.68 | DNM1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200039961-A1 | SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS | Epizyme, Inc. | 2020-02-06 | — | — | US | disclosed |